nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GARS—peripheral nervous system—type 2 diabetes mellitus	0.00792	0.0317	CbGeAlD
Glycine—GARS—nerve—type 2 diabetes mellitus	0.00618	0.0247	CbGeAlD
Glycine—GLYAT—nephron tubule—type 2 diabetes mellitus	0.00612	0.0245	CbGeAlD
Glycine—GRIN2C—nerve—type 2 diabetes mellitus	0.00608	0.0243	CbGeAlD
Glycine—GLYATL1—kidney—type 2 diabetes mellitus	0.00572	0.0229	CbGeAlD
Glycine—BAAT—liver—type 2 diabetes mellitus	0.00561	0.0225	CbGeAlD
Glycine—GLYAT—kidney—type 2 diabetes mellitus	0.00538	0.0215	CbGeAlD
Glycine—GLYAT—cortex of kidney—type 2 diabetes mellitus	0.00524	0.021	CbGeAlD
Glycine—GLYAT—adipose tissue—type 2 diabetes mellitus	0.00485	0.0194	CbGeAlD
Glycine—GNMT—islet of Langerhans—type 2 diabetes mellitus	0.00436	0.0175	CbGeAlD
Glycine—GRIN2A—nerve—type 2 diabetes mellitus	0.0042	0.0168	CbGeAlD
Glycine—Lung disorder—Sitagliptin—type 2 diabetes mellitus	0.00411	0.0143	CcSEcCtD
Glycine—Electrolyte imbalance—Irbesartan—type 2 diabetes mellitus	0.00409	0.0142	CcSEcCtD
Glycine—ALAS2—pancreas—type 2 diabetes mellitus	0.00405	0.0162	CbGeAlD
Glycine—L-Serine—SRR—type 2 diabetes mellitus	0.00396	0.254	CrCbGaD
Glycine—Aminocaproic Acid—PLAT—type 2 diabetes mellitus	0.00387	0.249	CrCbGaD
Glycine—PIPOX—islet of Langerhans—type 2 diabetes mellitus	0.00386	0.0155	CbGeAlD
Glycine—Hyponatraemia—Tolbutamide—type 2 diabetes mellitus	0.00378	0.0132	CcSEcCtD
Glycine—ALAS1—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.00378	0.342	CbGdCrCtD
Glycine—Encephalopathy—Glyburide—type 2 diabetes mellitus	0.00375	0.0131	CcSEcCtD
Glycine—AGXT—kidney—type 2 diabetes mellitus	0.00369	0.0148	CbGeAlD
Glycine—ALAS2—adipose tissue—type 2 diabetes mellitus	0.00367	0.0147	CbGeAlD
Glycine—GLYATL1—liver—type 2 diabetes mellitus	0.00362	0.0145	CbGeAlD
Glycine—Polyuria—Nateglinide—type 2 diabetes mellitus	0.00361	0.0126	CcSEcCtD
Glycine—GCSH—kidney—type 2 diabetes mellitus	0.00353	0.0141	CbGeAlD
Glycine—Hyponatraemia—Chlorpropamide—type 2 diabetes mellitus	0.00344	0.012	CcSEcCtD
Glycine—Hyponatraemia—Tolazamide—type 2 diabetes mellitus	0.00344	0.012	CcSEcCtD
Glycine—GLYAT—liver—type 2 diabetes mellitus	0.0034	0.0136	CbGeAlD
Glycine—GPR18—adipose tissue—type 2 diabetes mellitus	0.0034	0.0136	CbGeAlD
Glycine—Thirst—Nateglinide—type 2 diabetes mellitus	0.00333	0.0116	CcSEcCtD
Glycine—GLDC—nephron tubule—type 2 diabetes mellitus	0.00333	0.0133	CbGeAlD
Glycine—ALAS1—islet of Langerhans—type 2 diabetes mellitus	0.00328	0.0131	CbGeAlD
Glycine—Acidosis—Metformin—type 2 diabetes mellitus	0.00327	0.0114	CcSEcCtD
Glycine—GCSH—adipose tissue—type 2 diabetes mellitus	0.00318	0.0127	CbGeAlD
Glycine—L-Cysteine—CDO1—type 2 diabetes mellitus	0.00316	0.203	CrCbGaD
Glycine—AGXT2—kidney—type 2 diabetes mellitus	0.00313	0.0125	CbGeAlD
Glycine—PIPOX—nephron tubule—type 2 diabetes mellitus	0.00311	0.0125	CbGeAlD
Glycine—GNMT—pancreas—type 2 diabetes mellitus	0.00307	0.0123	CbGeAlD
Glycine—AGXT2—cortex of kidney—type 2 diabetes mellitus	0.00305	0.0122	CbGeAlD
Glycine—GLRA2—kidney—type 2 diabetes mellitus	0.003	0.012	CbGeAlD
Glycine—GARS—islet of Langerhans—type 2 diabetes mellitus	0.00299	0.012	CbGeAlD
Glycine—GLDC—kidney—type 2 diabetes mellitus	0.00293	0.0117	CbGeAlD
Glycine—Visual disturbance—Repaglinide—type 2 diabetes mellitus	0.0029	0.0101	CcSEcCtD
Glycine—GLDC—cortex of kidney—type 2 diabetes mellitus	0.00285	0.0114	CbGeAlD
Glycine—GATM—islet of Langerhans—type 2 diabetes mellitus	0.00284	0.0114	CbGeAlD
Glycine—PIPOX—kidney—type 2 diabetes mellitus	0.00273	0.0109	CbGeAlD
Glycine—PIPOX—pancreas—type 2 diabetes mellitus	0.00272	0.0109	CbGeAlD
Glycine—Coma—Glimepiride—type 2 diabetes mellitus	0.00267	0.0093	CcSEcCtD
Glycine—PIPOX—cortex of kidney—type 2 diabetes mellitus	0.00266	0.0107	CbGeAlD
Glycine—ALAS1—nephron tubule—type 2 diabetes mellitus	0.00264	0.0106	CbGeAlD
Glycine—Polyuria—Glipizide—type 2 diabetes mellitus	0.00259	0.00901	CcSEcCtD
Glycine—GCAT—cortex of kidney—type 2 diabetes mellitus	0.00258	0.0103	CbGeAlD
Glycine—ALAS2—liver—type 2 diabetes mellitus	0.00258	0.0103	CbGeAlD
Glycine—GARS—retina—type 2 diabetes mellitus	0.00256	0.0102	CbGeAlD
Glycine—L-Serine—CBS—type 2 diabetes mellitus	0.00255	0.164	CrCbGaD
Glycine—PIPOX—adipose tissue—type 2 diabetes mellitus	0.00246	0.00986	CbGeAlD
Glycine—GARS—nephron tubule—type 2 diabetes mellitus	0.00241	0.00964	CbGeAlD
Glycine—Visual disturbance—Glipizide—type 2 diabetes mellitus	0.0024	0.00835	CcSEcCtD
Glycine—GCAT—adipose tissue—type 2 diabetes mellitus	0.00239	0.00957	CbGeAlD
Glycine—Thirst—Glipizide—type 2 diabetes mellitus	0.00239	0.00832	CcSEcCtD
Glycine—ALAS1—cardiovascular system—type 2 diabetes mellitus	0.00238	0.00951	CbGeAlD
Glycine—Lightheadedness—Bromocriptine—type 2 diabetes mellitus	0.00236	0.00821	CcSEcCtD
Glycine—AGXT—liver—type 2 diabetes mellitus	0.00233	0.00933	CbGeAlD
Glycine—ALAS1—kidney—type 2 diabetes mellitus	0.00232	0.0093	CbGeAlD
Glycine—Angina pectoris—Repaglinide—type 2 diabetes mellitus	0.00231	0.00805	CcSEcCtD
Glycine—ALAS1—pancreas—type 2 diabetes mellitus	0.00231	0.00924	CbGeAlD
Glycine—Visual disturbance—Pioglitazone—type 2 diabetes mellitus	0.0023	0.008	CcSEcCtD
Glycine—ALAS1—Lisinopril—Ramipril—type 2 diabetes mellitus	0.0023	0.208	CbGdCrCtD
Glycine—GATM—nephron tubule—type 2 diabetes mellitus	0.00229	0.00915	CbGeAlD
Glycine—Hyponatraemia—Glipizide—type 2 diabetes mellitus	0.00228	0.00795	CcSEcCtD
Glycine—ALAS1—cortex of kidney—type 2 diabetes mellitus	0.00226	0.00906	CbGeAlD
Glycine—Cardiovascular disorder—Orlistat—type 2 diabetes mellitus	0.00224	0.00778	CcSEcCtD
Glycine—GCSH—liver—type 2 diabetes mellitus	0.00223	0.00894	CbGeAlD
Glycine—SHMT2—retina—type 2 diabetes mellitus	0.00223	0.00891	CbGeAlD
Glycine—GARS—cardiovascular system—type 2 diabetes mellitus	0.00216	0.00866	CbGeAlD
Glycine—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	0.00213	0.00741	CcSEcCtD
Glycine—GARS—kidney—type 2 diabetes mellitus	0.00212	0.00847	CbGeAlD
Glycine—GARS—pancreas—type 2 diabetes mellitus	0.0021	0.00842	CbGeAlD
Glycine—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.0021	0.00732	CcSEcCtD
Glycine—SHMT2—nephron tubule—type 2 diabetes mellitus	0.0021	0.00839	CbGeAlD
Glycine—ALAS1—adipose tissue—type 2 diabetes mellitus	0.00209	0.00839	CbGeAlD
Glycine—GARS—cortex of kidney—type 2 diabetes mellitus	0.00206	0.00825	CbGeAlD
Glycine—L-Cysteine—CBS—type 2 diabetes mellitus	0.00204	0.131	CrCbGaD
Glycine—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.00202	0.00703	CcSEcCtD
Glycine—GATM—kidney—type 2 diabetes mellitus	0.00201	0.00804	CbGeAlD
Glycine—GATM—pancreas—type 2 diabetes mellitus	0.002	0.00799	CbGeAlD
Glycine—AGXT2—liver—type 2 diabetes mellitus	0.00198	0.00793	CbGeAlD
Glycine—Coma—Gliclazide—type 2 diabetes mellitus	0.00198	0.00688	CcSEcCtD
Glycine—Back pain—Linagliptin—type 2 diabetes mellitus	0.00197	0.00688	CcSEcCtD
Glycine—GATM—cortex of kidney—type 2 diabetes mellitus	0.00196	0.00783	CbGeAlD
Glycine—GNMT—liver—type 2 diabetes mellitus	0.00195	0.00781	CbGeAlD
Glycine—ALAS1—Candesartan—Irbesartan—type 2 diabetes mellitus	0.00193	0.175	CbGdCrCtD
Glycine—GARS—adipose tissue—type 2 diabetes mellitus	0.00191	0.00764	CbGeAlD
Glycine—SHMT1—nephron tubule—type 2 diabetes mellitus	0.00191	0.00764	CbGeAlD
Glycine—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00191	0.00663	CcSEcCtD
Glycine—SHMT2—cardiovascular system—type 2 diabetes mellitus	0.00188	0.00753	CbGeAlD
Glycine—Vertigo—Tolazamide—type 2 diabetes mellitus	0.00185	0.00645	CcSEcCtD
Glycine—GLDC—liver—type 2 diabetes mellitus	0.00185	0.00741	CbGeAlD
Glycine—Back pain—Nateglinide—type 2 diabetes mellitus	0.00185	0.00644	CcSEcCtD
Glycine—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.00185	0.00643	CcSEcCtD
Glycine—SHMT2—kidney—type 2 diabetes mellitus	0.00184	0.00737	CbGeAlD
Glycine—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.00183	0.00638	CcSEcCtD
Glycine—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.00183	0.00638	CcSEcCtD
Glycine—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.00182	0.00634	CcSEcCtD
Glycine—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.00181	0.00632	CcSEcCtD
Glycine—GATM—adipose tissue—type 2 diabetes mellitus	0.00181	0.00725	CbGeAlD
Glycine—SHMT2—cortex of kidney—type 2 diabetes mellitus	0.00179	0.00718	CbGeAlD
Glycine—Polyuria—Gliclazide—type 2 diabetes mellitus	0.00179	0.00623	CcSEcCtD
Glycine—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.00179	0.00622	CcSEcCtD
Glycine—GSS—islet of Langerhans—type 2 diabetes mellitus	0.00178	0.00712	CbGeAlD
Glycine—GLRB—cardiovascular system—type 2 diabetes mellitus	0.00176	0.00706	CbGeAlD
Glycine—Hyponatraemia—Glyburide—type 2 diabetes mellitus	0.00176	0.00612	CcSEcCtD
Glycine—PIPOX—liver—type 2 diabetes mellitus	0.00173	0.00692	CbGeAlD
Glycine—SHMT1—kidney—type 2 diabetes mellitus	0.00168	0.00671	CbGeAlD
Glycine—GCAT—liver—type 2 diabetes mellitus	0.00168	0.00671	CbGeAlD
Glycine—SHMT2—adipose tissue—type 2 diabetes mellitus	0.00166	0.00664	CbGeAlD
Glycine—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.00166	0.00577	CcSEcCtD
Glycine—Thirst—Gliclazide—type 2 diabetes mellitus	0.00165	0.00575	CcSEcCtD
Glycine—ALAS1—Candesartan—Valsartan—type 2 diabetes mellitus	0.00164	0.149	CbGdCrCtD
Glycine—SHMT1—cortex of kidney—type 2 diabetes mellitus	0.00163	0.00654	CbGeAlD
Glycine—SLC36A1—nephron tubule—type 2 diabetes mellitus	0.00163	0.00651	CbGeAlD
Glycine—Polyuria—Orlistat—type 2 diabetes mellitus	0.00162	0.00565	CcSEcCtD
Glycine—Lightheadedness—Metformin—type 2 diabetes mellitus	0.00162	0.00564	CcSEcCtD
Glycine—Oedema—Acarbose—type 2 diabetes mellitus	0.00162	0.00563	CcSEcCtD
Glycine—Back pain—Repaglinide—type 2 diabetes mellitus	0.0016	0.00557	CcSEcCtD
Glycine—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	0.00158	0.00549	CcSEcCtD
Glycine—Rhinitis—Glipizide—type 2 diabetes mellitus	0.00158	0.00549	CcSEcCtD
Glycine—GLRB—adipose tissue—type 2 diabetes mellitus	0.00156	0.00623	CbGeAlD
Glycine—Lightheadedness—Irbesartan—type 2 diabetes mellitus	0.00153	0.00532	CcSEcCtD
Glycine—GSS—retina—type 2 diabetes mellitus	0.00152	0.00609	CbGeAlD
Glycine—Visual impairment—Glipizide—type 2 diabetes mellitus	0.00152	0.00528	CcSEcCtD
Glycine—Back pain—Rosiglitazone—type 2 diabetes mellitus	0.00151	0.00527	CcSEcCtD
Glycine—SHMT1—adipose tissue—type 2 diabetes mellitus	0.00151	0.00605	CbGeAlD
Glycine—Thirst—Orlistat—type 2 diabetes mellitus	0.0015	0.00522	CcSEcCtD
Glycine—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00147	0.00512	CcSEcCtD
Glycine—ALAS1—liver—type 2 diabetes mellitus	0.00147	0.00588	CbGeAlD
Glycine—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.00145	0.00505	CcSEcCtD
Glycine—Hyponatraemia—Valsartan—type 2 diabetes mellitus	0.00145	0.00504	CcSEcCtD
Glycine—GSS—nephron tubule—type 2 diabetes mellitus	0.00143	0.00573	CbGeAlD
Glycine—SLC36A1—kidney—type 2 diabetes mellitus	0.00143	0.00572	CbGeAlD
Glycine—SLC36A1—pancreas—type 2 diabetes mellitus	0.00142	0.00569	CbGeAlD
Glycine—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.00141	0.00492	CcSEcCtD
Glycine—Chills—Glipizide—type 2 diabetes mellitus	0.00141	0.00491	CcSEcCtD
Glycine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00141	0.0049	CcSEcCtD
Glycine—ALAS1—Candesartan—Losartan—type 2 diabetes mellitus	0.0014	0.127	CbGdCrCtD
Glycine—SLC36A1—cortex of kidney—type 2 diabetes mellitus	0.00139	0.00557	CbGeAlD
Glycine—Oedema—Repaglinide—type 2 diabetes mellitus	0.00135	0.0047	CcSEcCtD
Glycine—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00134	0.00466	CcSEcCtD
Glycine—GARS—liver—type 2 diabetes mellitus	0.00134	0.00536	CbGeAlD
Glycine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00134	0.00466	CcSEcCtD
Glycine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00134	0.00466	CcSEcCtD
Glycine—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00133	0.00462	CcSEcCtD
Glycine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00132	0.00461	CcSEcCtD
Glycine—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.00132	0.0046	CcSEcCtD
Glycine—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.00131	0.00456	CcSEcCtD
Glycine—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00129	0.00449	CcSEcCtD
Glycine—SLC36A1—adipose tissue—type 2 diabetes mellitus	0.00129	0.00516	CbGeAlD
Glycine—GSS—cardiovascular system—type 2 diabetes mellitus	0.00129	0.00515	CbGeAlD
Glycine—Urticaria—Acarbose—type 2 diabetes mellitus	0.00129	0.00447	CcSEcCtD
Glycine—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.00128	0.00444	CcSEcCtD
Glycine—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.00128	0.00444	CcSEcCtD
Glycine—GATM—liver—type 2 diabetes mellitus	0.00127	0.00508	CbGeAlD
Glycine—Back pain—Pioglitazone—type 2 diabetes mellitus	0.00127	0.00442	CcSEcCtD
Glycine—GSS—kidney—type 2 diabetes mellitus	0.00126	0.00504	CbGeAlD
Glycine—GSS—pancreas—type 2 diabetes mellitus	0.00125	0.00501	CbGeAlD
Glycine—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	0.00124	0.00434	CcSEcCtD
Glycine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00124	0.00431	CcSEcCtD
Glycine—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.00123	0.00429	CcSEcCtD
Glycine—Back pain—Sitagliptin—type 2 diabetes mellitus	0.00123	0.00429	CcSEcCtD
Glycine—Vertigo—Glipizide—type 2 diabetes mellitus	0.00123	0.00428	CcSEcCtD
Glycine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00123	0.00427	CcSEcCtD
Glycine—GSS—cortex of kidney—type 2 diabetes mellitus	0.00123	0.00491	CbGeAlD
Glycine—Nausea—Miglitol—type 2 diabetes mellitus	0.00122	0.00426	CcSEcCtD
Glycine—Dehydration—Metformin—type 2 diabetes mellitus	0.00122	0.00426	CcSEcCtD
Glycine—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.0012	0.00419	CcSEcCtD
Glycine—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.0012	0.00418	CcSEcCtD
Glycine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00119	0.00415	CcSEcCtD
Glycine—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00118	0.0041	CcSEcCtD
Glycine—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.00117	0.00408	CcSEcCtD
Glycine—Visual impairment—Glyburide—type 2 diabetes mellitus	0.00117	0.00406	CcSEcCtD
Glycine—SHMT2—liver—type 2 diabetes mellitus	0.00116	0.00466	CbGeAlD
Glycine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00115	0.00401	CcSEcCtD
Glycine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00115	0.004	CcSEcCtD
Glycine—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00114	0.00398	CcSEcCtD
Glycine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00114	0.00397	CcSEcCtD
Glycine—Polyuria—Ramipril—type 2 diabetes mellitus	0.00114	0.00397	CcSEcCtD
Glycine—GSS—adipose tissue—type 2 diabetes mellitus	0.00113	0.00454	CbGeAlD
Glycine—Oedema—Glipizide—type 2 diabetes mellitus	0.00112	0.00389	CcSEcCtD
Glycine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00111	0.00388	CcSEcCtD
Glycine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00111	0.00388	CcSEcCtD
Glycine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00111	0.00385	CcSEcCtD
Glycine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00111	0.00385	CcSEcCtD
Glycine—Angina pectoris—Metformin—type 2 diabetes mellitus	0.00111	0.00385	CcSEcCtD
Glycine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.0011	0.00383	CcSEcCtD
Glycine—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00109	0.00379	CcSEcCtD
Glycine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00378	CcSEcCtD
Glycine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00107	0.00373	CcSEcCtD
Glycine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00107	0.00373	CcSEcCtD
Glycine—Oedema—Pioglitazone—type 2 diabetes mellitus	0.00107	0.00373	CcSEcCtD
Glycine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00107	0.00372	CcSEcCtD
Glycine—SHMT1—liver—type 2 diabetes mellitus	0.00106	0.00424	CbGeAlD
Glycine—SLC16A10—nephron tubule—type 2 diabetes mellitus	0.00105	0.0042	CbGeAlD
Glycine—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.00105	0.00365	CcSEcCtD
Glycine—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.00104	0.00364	CcSEcCtD
Glycine—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00104	0.0036	CcSEcCtD
Glycine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00103	0.00359	CcSEcCtD
Glycine—Vomiting—Acarbose—type 2 diabetes mellitus	0.00103	0.00358	CcSEcCtD
Glycine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00102	0.00354	CcSEcCtD
Glycine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00101	0.00353	CcSEcCtD
Glycine—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.001	0.0035	CcSEcCtD
Glycine—Rhinitis—Valsartan—type 2 diabetes mellitus	0.001	0.00348	CcSEcCtD
Glycine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.001	0.00348	CcSEcCtD
Glycine—Nausea—Tolazamide—type 2 diabetes mellitus	0.001	0.00348	CcSEcCtD
Glycine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000998	0.00348	CcSEcCtD
Glycine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000995	0.00346	CcSEcCtD
Glycine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000993	0.00346	CcSEcCtD
Glycine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000992	0.00345	CcSEcCtD
Glycine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000982	0.00342	CcSEcCtD
Glycine—Chills—Gliclazide—type 2 diabetes mellitus	0.000975	0.00339	CcSEcCtD
Glycine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000974	0.00339	CcSEcCtD
Glycine—Nausea—Acarbose—type 2 diabetes mellitus	0.000961	0.00335	CcSEcCtD
Glycine—Pain—Glipizide—type 2 diabetes mellitus	0.000955	0.00333	CcSEcCtD
Glycine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00094	0.00327	CcSEcCtD
Glycine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000926	0.00323	CcSEcCtD
Glycine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000924	0.00322	CcSEcCtD
Glycine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000918	0.0032	CcSEcCtD
Glycine—Back pain—Gliclazide—type 2 diabetes mellitus	0.000915	0.00319	CcSEcCtD
Glycine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000913	0.00318	CcSEcCtD
Glycine—Rhinitis—Metformin—type 2 diabetes mellitus	0.000911	0.00317	CcSEcCtD
Glycine—SLC36A1—liver—type 2 diabetes mellitus	0.000904	0.00362	CbGeAlD
Glycine—SLC16A10—cortex of kidney—type 2 diabetes mellitus	0.000898	0.00359	CbGeAlD
Glycine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000889	0.00309	CcSEcCtD
Glycine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000887	0.00309	CcSEcCtD
Glycine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000879	0.00306	CcSEcCtD
Glycine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000873	0.00304	CcSEcCtD
Glycine—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00086	0.00299	CcSEcCtD
Glycine—Oedema—Glyburide—type 2 diabetes mellitus	0.00086	0.00299	CcSEcCtD
Glycine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000858	0.00299	CcSEcCtD
Glycine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00085	0.00296	CcSEcCtD
Glycine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000844	0.00294	CcSEcCtD
Glycine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000842	0.00293	CcSEcCtD
Glycine—Back pain—Valsartan—type 2 diabetes mellitus	0.000841	0.00293	CcSEcCtD
Glycine—SLC16A10—adipose tissue—type 2 diabetes mellitus	0.000831	0.00333	CbGeAlD
Glycine—Back pain—Orlistat—type 2 diabetes mellitus	0.000831	0.00289	CcSEcCtD
Glycine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000828	0.00288	CcSEcCtD
Glycine—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000827	0.00288	CcSEcCtD
Glycine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000825	0.00287	CcSEcCtD
Glycine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000823	0.00287	CcSEcCtD
Glycine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000819	0.00285	CcSEcCtD
Glycine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000819	0.00285	CcSEcCtD
Glycine—Chills—Metformin—type 2 diabetes mellitus	0.000816	0.00284	CcSEcCtD
Glycine—Rhinitis—Losartan—type 2 diabetes mellitus	0.000809	0.00282	CcSEcCtD
Glycine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000809	0.00282	CcSEcCtD
Glycine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000803	0.0028	CcSEcCtD
Glycine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000802	0.00279	CcSEcCtD
Glycine—GSS—liver—type 2 diabetes mellitus	0.000796	0.00319	CbGeAlD
Glycine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000788	0.00275	CcSEcCtD
Glycine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000781	0.00272	CcSEcCtD
Glycine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000771	0.00269	CcSEcCtD
Glycine—Chills—Irbesartan—type 2 diabetes mellitus	0.00077	0.00268	CcSEcCtD
Glycine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000768	0.00267	CcSEcCtD
Glycine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000766	0.00267	CcSEcCtD
Glycine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000764	0.00266	CcSEcCtD
Glycine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000758	0.00264	CcSEcCtD
Glycine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000753	0.00262	CcSEcCtD
Glycine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000747	0.0026	CcSEcCtD
Glycine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000746	0.0026	CcSEcCtD
Glycine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000744	0.00259	CcSEcCtD
Glycine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000739	0.00257	CcSEcCtD
Glycine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000732	0.00255	CcSEcCtD
Glycine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000721	0.00251	CcSEcCtD
Glycine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000713	0.00248	CcSEcCtD
Glycine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000711	0.00248	CcSEcCtD
Glycine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00071	0.00247	CcSEcCtD
Glycine—Oedema—Valsartan—type 2 diabetes mellitus	0.000709	0.00247	CcSEcCtD
Glycine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000708	0.00246	CcSEcCtD
Glycine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000704	0.00245	CcSEcCtD
Glycine—Oedema—Orlistat—type 2 diabetes mellitus	0.000701	0.00244	CcSEcCtD
Glycine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000689	0.0024	CcSEcCtD
Glycine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000687	0.00239	CcSEcCtD
Glycine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000683	0.00238	CcSEcCtD
Glycine—Back pain—Losartan—type 2 diabetes mellitus	0.00068	0.00237	CcSEcCtD
Glycine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000671	0.00234	CcSEcCtD
Glycine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000667	0.00232	CcSEcCtD
Glycine—Nausea—Glipizide—type 2 diabetes mellitus	0.000663	0.00231	CcSEcCtD
Glycine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000663	0.00231	CcSEcCtD
Glycine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000663	0.00231	CcSEcCtD
Glycine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000662	0.00231	CcSEcCtD
Glycine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000661	0.0023	CcSEcCtD
Glycine—Pain—Gliclazide—type 2 diabetes mellitus	0.00066	0.0023	CcSEcCtD
Glycine—Oedema—Metformin—type 2 diabetes mellitus	0.000646	0.00225	CcSEcCtD
Glycine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000643	0.00224	CcSEcCtD
Glycine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000633	0.00221	CcSEcCtD
Glycine—Vertigo—Losartan—type 2 diabetes mellitus	0.000631	0.0022	CcSEcCtD
Glycine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000622	0.00217	CcSEcCtD
Glycine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000619	0.00216	CcSEcCtD
Glycine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000617	0.00215	CcSEcCtD
Glycine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000613	0.00214	CcSEcCtD
Glycine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000609	0.00212	CcSEcCtD
Glycine—Hypotension—Metformin—type 2 diabetes mellitus	0.000603	0.0021	CcSEcCtD
Glycine—Pain—Orlistat—type 2 diabetes mellitus	0.000599	0.00209	CcSEcCtD
Glycine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000598	0.00208	CcSEcCtD
Glycine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000595	0.00207	CcSEcCtD
Glycine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000588	0.00205	CcSEcCtD
Glycine—SLC16A10—liver—type 2 diabetes mellitus	0.000583	0.00233	CbGeAlD
Glycine—Oedema—Losartan—type 2 diabetes mellitus	0.000574	0.002	CcSEcCtD
Glycine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000569	0.00198	CcSEcCtD
Glycine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000569	0.00198	CcSEcCtD
Glycine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000563	0.00196	CcSEcCtD
Glycine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00056	0.00195	CcSEcCtD
Glycine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000559	0.00195	CcSEcCtD
Glycine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000557	0.00194	CcSEcCtD
Glycine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000547	0.0019	CcSEcCtD
Glycine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000541	0.00189	CcSEcCtD
Glycine—Hypotension—Losartan—type 2 diabetes mellitus	0.000536	0.00187	CcSEcCtD
Glycine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000528	0.00184	CcSEcCtD
Glycine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000522	0.00182	CcSEcCtD
Glycine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000522	0.00182	CcSEcCtD
Glycine—Pain—Irbesartan—type 2 diabetes mellitus	0.000521	0.00181	CcSEcCtD
Glycine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000516	0.0018	CcSEcCtD
Glycine—Urticaria—Metformin—type 2 diabetes mellitus	0.000513	0.00179	CcSEcCtD
Glycine—Nausea—Glyburide—type 2 diabetes mellitus	0.000511	0.00178	CcSEcCtD
Glycine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00051	0.00178	CcSEcCtD
Glycine—Oedema—Ramipril—type 2 diabetes mellitus	0.000492	0.00171	CcSEcCtD
Glycine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000491	0.00171	CcSEcCtD
Glycine—Pain—Losartan—type 2 diabetes mellitus	0.00049	0.00171	CcSEcCtD
Glycine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000485	0.00169	CcSEcCtD
Glycine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000484	0.00169	CcSEcCtD
Glycine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00048	0.00167	CcSEcCtD
Glycine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000479	0.00167	CcSEcCtD
Glycine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000469	0.00163	CcSEcCtD
Glycine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000463	0.00161	CcSEcCtD
Glycine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00046	0.0016	CcSEcCtD
Glycine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000458	0.0016	CcSEcCtD
Glycine—Urticaria—Losartan—type 2 diabetes mellitus	0.000456	0.00159	CcSEcCtD
Glycine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000451	0.00157	CcSEcCtD
Glycine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000449	0.00156	CcSEcCtD
Glycine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000446	0.00155	CcSEcCtD
Glycine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000442	0.00154	CcSEcCtD
Glycine—Dizziness—Metformin—type 2 diabetes mellitus	0.000427	0.00149	CcSEcCtD
Glycine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000423	0.00147	CcSEcCtD
Glycine—Nausea—Valsartan—type 2 diabetes mellitus	0.000421	0.00147	CcSEcCtD
Glycine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000417	0.00145	CcSEcCtD
Glycine—Nausea—Orlistat—type 2 diabetes mellitus	0.000416	0.00145	CcSEcCtD
Glycine—Vomiting—Metformin—type 2 diabetes mellitus	0.000411	0.00143	CcSEcCtD
Glycine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000403	0.0014	CcSEcCtD
Glycine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000392	0.00137	CcSEcCtD
Glycine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000391	0.00136	CcSEcCtD
Glycine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000387	0.00135	CcSEcCtD
Glycine—Nausea—Metformin—type 2 diabetes mellitus	0.000384	0.00134	CcSEcCtD
Glycine—Dizziness—Losartan—type 2 diabetes mellitus	0.000379	0.00132	CcSEcCtD
Glycine—Vomiting—Losartan—type 2 diabetes mellitus	0.000365	0.00127	CcSEcCtD
Glycine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000362	0.00126	CcSEcCtD
Glycine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000362	0.00126	CcSEcCtD
Glycine—Nausea—Losartan—type 2 diabetes mellitus	0.000341	0.00119	CcSEcCtD
Glycine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000336	0.00117	CcSEcCtD
Glycine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000325	0.00113	CcSEcCtD
Glycine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000313	0.00109	CcSEcCtD
Glycine—Nausea—Ramipril—type 2 diabetes mellitus	0.000292	0.00102	CcSEcCtD
Glycine—GLYAT—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-05	8.12e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-05	8.12e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-05	8.12e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-05	8.12e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-05	8.1e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOE—type 2 diabetes mellitus	3.53e-05	8.09e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOE—type 2 diabetes mellitus	3.53e-05	8.09e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOE—type 2 diabetes mellitus	3.53e-05	8.09e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—APOE—type 2 diabetes mellitus	3.53e-05	8.09e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LPL—type 2 diabetes mellitus	3.52e-05	8.07e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADCY5—type 2 diabetes mellitus	3.51e-05	8.04e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—GPX1—type 2 diabetes mellitus	3.49e-05	8.01e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—NOS3—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CTGF—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOA1—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOA1—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOA1—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—APOA1—type 2 diabetes mellitus	3.49e-05	8e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.47e-05	7.96e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—LPL—type 2 diabetes mellitus	3.47e-05	7.95e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMGCR—type 2 diabetes mellitus	3.46e-05	7.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.45e-05	7.9e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AGT—type 2 diabetes mellitus	3.44e-05	7.88e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CD36—type 2 diabetes mellitus	3.4e-05	7.8e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADCY5—type 2 diabetes mellitus	3.4e-05	7.78e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ADRA2A—type 2 diabetes mellitus	3.39e-05	7.76e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-05	7.76e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-05	7.75e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOE—type 2 diabetes mellitus	3.37e-05	7.72e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPP2CA—type 2 diabetes mellitus	3.36e-05	7.7e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.35e-05	7.67e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GNB3—type 2 diabetes mellitus	3.35e-05	7.67e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.34e-05	7.65e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HMOX1—type 2 diabetes mellitus	3.33e-05	7.63e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOA1—type 2 diabetes mellitus	3.33e-05	7.63e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.31e-05	7.57e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.3e-05	7.56e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.3e-05	7.56e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CD36—type 2 diabetes mellitus	3.3e-05	7.55e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.29e-05	7.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFBR2—type 2 diabetes mellitus	3.29e-05	7.53e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAT—type 2 diabetes mellitus	3.29e-05	7.53e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.28e-05	7.51e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.26e-05	7.46e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP2E1—type 2 diabetes mellitus	3.25e-05	7.45e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.25e-05	7.44e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.25e-05	7.44e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.24e-05	7.41e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—type 2 diabetes mellitus	3.23e-05	7.39e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.22e-05	7.38e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A1—type 2 diabetes mellitus	3.22e-05	7.37e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1A2—type 2 diabetes mellitus	3.22e-05	7.37e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-05	7.32e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOB—type 2 diabetes mellitus	3.19e-05	7.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN2B—type 2 diabetes mellitus	3.18e-05	7.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—C3—type 2 diabetes mellitus	3.17e-05	7.27e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARA—type 2 diabetes mellitus	3.16e-05	7.25e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.16e-05	7.25e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GCG—type 2 diabetes mellitus	3.16e-05	7.25e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.14e-05	7.19e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP3A4—type 2 diabetes mellitus	3.14e-05	7.19e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-05	7.16e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOB—type 2 diabetes mellitus	3.11e-05	7.12e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—type 2 diabetes mellitus	3.1e-05	7.11e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GCG—type 2 diabetes mellitus	3.08e-05	7.07e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A4—type 2 diabetes mellitus	3.08e-05	7.07e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-05	7.05e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-05	7.05e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-05	7.05e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-05	7.05e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AGT—type 2 diabetes mellitus	3.06e-05	7.02e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-05	7.02e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—LPL—type 2 diabetes mellitus	3.05e-05	6.98e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.02e-05	6.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.02e-05	6.91e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—INS—type 2 diabetes mellitus	3.02e-05	6.91e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—INS—type 2 diabetes mellitus	3.02e-05	6.91e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—INS—type 2 diabetes mellitus	3.02e-05	6.91e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—INS—type 2 diabetes mellitus	3.02e-05	6.91e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AGT—type 2 diabetes mellitus	3.01e-05	6.91e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CALM1—type 2 diabetes mellitus	3.01e-05	6.91e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOE—type 2 diabetes mellitus	3e-05	6.88e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADCY5—type 2 diabetes mellitus	2.98e-05	6.83e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—type 2 diabetes mellitus	2.97e-05	6.81e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOA1—type 2 diabetes mellitus	2.97e-05	6.8e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AGT—type 2 diabetes mellitus	2.97e-05	6.8e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—LPL—type 2 diabetes mellitus	2.96e-05	6.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.96e-05	6.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LEP—type 2 diabetes mellitus	2.95e-05	6.77e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOE—type 2 diabetes mellitus	2.95e-05	6.77e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—type 2 diabetes mellitus	2.93e-05	6.72e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.93e-05	6.72e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.92e-05	6.69e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CALM1—type 2 diabetes mellitus	2.92e-05	6.69e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOE—type 2 diabetes mellitus	2.91e-05	6.66e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ADCY5—type 2 diabetes mellitus	2.9e-05	6.65e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CD36—type 2 diabetes mellitus	2.89e-05	6.63e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—INS—type 2 diabetes mellitus	2.88e-05	6.6e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-05	6.59e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.86e-05	6.55e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.78e-05	6.38e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PPP2CA—type 2 diabetes mellitus	2.78e-05	6.37e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—type 2 diabetes mellitus	2.77e-05	6.34e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—type 2 diabetes mellitus	2.77e-05	6.34e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—type 2 diabetes mellitus	2.77e-05	6.34e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—type 2 diabetes mellitus	2.77e-05	6.34e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—type 2 diabetes mellitus	2.74e-05	6.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CCR5—type 2 diabetes mellitus	2.73e-05	6.26e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.73e-05	6.25e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNB3—type 2 diabetes mellitus	2.73e-05	6.25e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMOX1—type 2 diabetes mellitus	2.71e-05	6.22e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARA—type 2 diabetes mellitus	2.69e-05	6.17e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAT—type 2 diabetes mellitus	2.68e-05	6.14e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—type 2 diabetes mellitus	2.67e-05	6.12e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.66e-05	6.09e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GNB3—type 2 diabetes mellitus	2.66e-05	6.09e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMOX1—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-05	6.06e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—type 2 diabetes mellitus	2.64e-05	6.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.63e-05	6.04e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—type 2 diabetes mellitus	2.62e-05	5.99e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAT—type 2 diabetes mellitus	2.61e-05	5.98e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AGT—type 2 diabetes mellitus	2.61e-05	5.97e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOB—type 2 diabetes mellitus	2.6e-05	5.96e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—INS—type 2 diabetes mellitus	2.57e-05	5.88e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CALM1—type 2 diabetes mellitus	2.56e-05	5.87e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOE—type 2 diabetes mellitus	2.55e-05	5.85e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—type 2 diabetes mellitus	2.55e-05	5.83e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS2—type 2 diabetes mellitus	2.54e-05	5.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOB—type 2 diabetes mellitus	2.53e-05	5.81e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-05	5.8e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—type 2 diabetes mellitus	2.53e-05	5.8e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOA1—type 2 diabetes mellitus	2.52e-05	5.78e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-05	5.78e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-05	5.78e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—INS—type 2 diabetes mellitus	2.52e-05	5.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CALM1—type 2 diabetes mellitus	2.49e-05	5.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOE—type 2 diabetes mellitus	2.49e-05	5.7e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—INS—type 2 diabetes mellitus	2.48e-05	5.69e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—LPL—type 2 diabetes mellitus	2.48e-05	5.69e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.48e-05	5.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.48e-05	5.69e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—type 2 diabetes mellitus	2.47e-05	5.65e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOA1—type 2 diabetes mellitus	2.46e-05	5.63e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.44e-05	5.59e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.44e-05	5.59e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADCY5—type 2 diabetes mellitus	2.43e-05	5.57e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.43e-05	5.56e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—LPL—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-05	5.55e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-05	5.43e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-05	5.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CD36—type 2 diabetes mellitus	2.36e-05	5.41e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—type 2 diabetes mellitus	2.35e-05	5.39e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.33e-05	5.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.32e-05	5.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—type 2 diabetes mellitus	2.32e-05	5.31e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-05	5.29e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CD36—type 2 diabetes mellitus	2.3e-05	5.27e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—type 2 diabetes mellitus	2.28e-05	5.22e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-05	5.2e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-05	5.16e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-05	5.16e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-05	5.12e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—type 2 diabetes mellitus	2.22e-05	5.1e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS1—type 2 diabetes mellitus	2.22e-05	5.08e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.21e-05	5.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.21e-05	5.07e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARA—type 2 diabetes mellitus	2.19e-05	5.03e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—INS—type 2 diabetes mellitus	2.18e-05	5e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-05	4.99e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-05	4.99e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-05	4.99e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARA—type 2 diabetes mellitus	2.14e-05	4.9e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AGT—type 2 diabetes mellitus	2.12e-05	4.87e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—INS—type 2 diabetes mellitus	2.12e-05	4.87e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CALM1—type 2 diabetes mellitus	2.09e-05	4.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RELA—type 2 diabetes mellitus	2.08e-05	4.77e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOE—type 2 diabetes mellitus	2.08e-05	4.77e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AGT—type 2 diabetes mellitus	2.07e-05	4.74e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—type 2 diabetes mellitus	2.06e-05	4.73e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-05	4.71e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOA1—type 2 diabetes mellitus	2.06e-05	4.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT2—type 2 diabetes mellitus	2.05e-05	4.7e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-05	4.66e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOE—type 2 diabetes mellitus	2.03e-05	4.65e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-05	4.59e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—type 2 diabetes mellitus	2e-05	4.58e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-05	4.57e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.97e-05	4.51e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SERPINE1—type 2 diabetes mellitus	1.95e-05	4.47e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NOS3—type 2 diabetes mellitus	1.91e-05	4.38e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.91e-05	4.38e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.9e-05	4.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-05	4.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-05	4.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS3—type 2 diabetes mellitus	1.86e-05	4.27e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3R1—type 2 diabetes mellitus	1.86e-05	4.27e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—type 2 diabetes mellitus	1.81e-05	4.15e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—INS—type 2 diabetes mellitus	1.78e-05	4.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.77e-05	4.07e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-05	4.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-05	4.02e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-05	4.01e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—INS—type 2 diabetes mellitus	1.73e-05	3.97e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.72e-05	3.94e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—type 2 diabetes mellitus	1.7e-05	3.9e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-05	3.75e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—type 2 diabetes mellitus	1.63e-05	3.74e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-05	3.68e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.59e-05	3.65e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—type 2 diabetes mellitus	1.59e-05	3.64e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-05	3.57e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-05	3.57e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-05	3.48e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-05	3.48e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-05	3.35e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-05	3.29e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-05	3.27e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-05	3.18e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—type 2 diabetes mellitus	1.38e-05	3.16e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—type 2 diabetes mellitus	1.23e-05	2.82e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-05	2.79e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-05	2.79e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-05	2.79e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-05	2.79e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—type 2 diabetes mellitus	1.21e-05	2.77e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-05	2.66e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-05	2.53e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-05	2.37e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-05	2.33e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—type 2 diabetes mellitus	1e-05	2.3e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—type 2 diabetes mellitus	9.28e-06	2.13e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—type 2 diabetes mellitus	8.79e-06	2.01e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—type 2 diabetes mellitus	8.56e-06	1.96e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—type 2 diabetes mellitus	7.17e-06	1.64e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—type 2 diabetes mellitus	6.99e-06	1.6e-05	CbGpPWpGaD
